<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00390000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P02730</UniProt_ID>
  <Seq_Length>911</Seq_Length>
  <Molecule_Weight>101792</Molecule_Weight>
  <KEGG_ID>hsa:6521</KEGG_ID>
  <Orthology_ID>K06573</Orthology_ID>
  <Function_Summary>Band 3 is the major integral glycoprotein of the erythrocyte membrane. Band 3 has two functional domains. Its integral domain mediates a 1:1 exchange of inorganic anions across the membrane, whereas its cytoplasmic domain provides binding sites for cytoskeletal proteins, glycolytic enzymes, and hemoglobin.</Function_Summary>
  <Pfam_ID>PF07565:Band_3_cyto@@PF00955:HCO3_cotransp</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>6</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Erythrocyte membrane protein band 3</Alias>
      <Alias>Band 3</Alias>
      <Alias>Solute carrier family 4 member 1</Alias>
      <Alias>AE 1</Alias>
      <Alias>Anion exchange protein 1</Alias>
      <Alias>Erythroid anion exchange protein</Alias>
      <Alias>Solute carrier family 4 member 1</Alias>
      <Alias>CD_antigen=CD233</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Protein belonging to the set of cell surface antigens found chiefly, but not solely, on blood cells. More than fifteen different blood group systems are recognised in humans. In most cases the antigenic determinant resides in the carbohydrate chains of membrane glycoproteins or glycolipids.</Detail>
      <Keyword>Blood group antigen</Keyword>
      <Ontology_ID>KW-0095</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an identical protein to form a homodimer.</Detail>
      <Keyword>Protein homodimerization activity</Keyword>
      <Ontology_ID>GO:0042803</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ankyrin, a 200 kDa cytoskeletal protein that attaches other cytoskeletal proteins to integral membrane proteins.</Detail>
      <Keyword>Ankyrin binding</Keyword>
      <Ontology_ID>GO:0030506</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of chloride ions from one side of a membrane to the other.</Detail>
      <Keyword>Chloride transmembrane transporter activity</Keyword>
      <Ontology_ID>GO:0015108</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: anion A(out) + anion B(in) = anion A(in) + anion B(out).</Detail>
      <Keyword>Anion</Keyword>
      <Ontology_ID>GO:0015301</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with both a protein or protein complex and a membrane, in order to maintain the localization of the protein at a specific location on the membrane.</Detail>
      <Keyword>Protein anchor</Keyword>
      <Ontology_ID>GO:0043495</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: inorganic anion A(out) + inorganic anion B(in) = inorganic anion A(in) + inorganic anion B(out).</Detail>
      <Keyword>Inorganic anion exchanger activity</Keyword>
      <Ontology_ID>GO:0005452</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>455</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>837</Position>
      <Original>Thr</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>808</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>870</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>760</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>609</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>707</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>862</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>687</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>646</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>868</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>73</Position>
      <Original>Leu</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>432</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>771</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>557</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>566</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>834</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>561</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>832</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>130</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>656</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>589</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>40</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>613</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>690</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>783</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>147</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>490</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>429</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>837</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>480</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>548</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>705</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>760</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>285</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>589</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>561</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>56</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>566</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>518</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>858</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>68</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>714</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>586</Position>
      <Original>Met</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>555</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>589</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>658</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>701</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>327</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>45</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>38</Position>
      <Original>Asp</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>442</Position>
      <Original>Ile</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>731</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>646</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>508</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>552</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>569</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>688</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>455</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>72</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>734</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>837</Position>
      <Original>Thr</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>854</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>488</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>112</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>90</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>565</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>551</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>663</Position>
      <Original>Met</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>602</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>27</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>656</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>773</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>490</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>808</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process involved in the maintenance of an internal steady state of ions at the level of a cell.</Detail>
      <Keyword>Cellular ion homeostasis</Keyword>
      <Ontology_ID>GO:0006873</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Ion transport</Keyword>
      <Ontology_ID>GO:0006811</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of bicarbonate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Bicarbonate transport</Keyword>
      <Ontology_ID>GO:0015701</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Transport</Keyword>
      <Ontology_ID>GO:0006810</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>359</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>8</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>46</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>21</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>350</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>1</Position>
      <PTM_Type>N-acetylmethionine</PTM_Type>
    </PTM>
    <PTM>
      <Position>904</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MEELQDDYEDMMEENLEQEEYEDPDIPESQMEEPAAHDTEATATDYHTTSHPGTHKVYVELQELVMDEKNQELRWMEAARWVQLEENLGENGAWGRPHLSHLTFWSLLELRRVFTKGTVLLDLQETSLAGVANQLLDRFIFEDQIRPQDREELLRALLLKHSHAGELEALGGVKPAVLTRSGDPSQPLLPQHSSLETQLFCEQGDGGTEGHSPSGILEKIPPDSEATLVLVGRADFLEQPVLGFVRLQEAAELEAVELPVPIRFLFVLLGPEAPHIDYTQLGRAAATLMSERVFRIDAYMAQSRGELLHSLEGFLDCSLVLPPTDAPSEQALLSLVPVQRELLRRRYQSSPAKPDSSFYKGLDLNGGPDDPLQQTGQLFGGLVRDIRRRYPYYLSDITDAFSPQVLAAVIFIYFAALSPAITFGGLLGEKTRNQMGVSELLISTAVQGILFALLGAQPLLVVGFSGPLLVFEEAFFSFCETNGLEYIVGRVWIGFWLILLVVLVVAFEGSFLVRFISRYTQEIFSFLISLIFIYETFSKLIKIFQDHPLQKTYNYNVLMVPKPQGPLPNTALLSLVLMAGTFFFAMMLRKFKNSSYFPGKLRRVIGDFGVPISILIMVLVDFFIQDTYTQKLSVPDGFKVSNSSARGWVIHPLGLRSEFPIWMMFASALPALLVFILIFLESQITTLIVSKPERKMVKGSGFHLDLLLVVGMGGVAALFGMPWLSATTVRSVTHANALTVMGKASTPGAAAQIQEVKEQRISGLLVAVLVGLSILMEPILSRIPLAVLFGIFLYMGVTSLSGIQLFDRILLLFKPPKYHPDVPYVKRVKTWRMHLFTGIQIICLAVLWVVKSTPASLALPFVLILTVPLRRVLLPLIFRNVELQCLDADDAKATFDEEEGRDEYDEVAMPV</Protein_Seq>
    <DNA_Seq>GGAACGAGTGGGAACGTAGCTGGTCGCAGAGGGCACCAGCGGCTGCAGGACTTCACCAAGGGACCCTGAGGCTCGTGAGCAGGGACCCGCGGTGCGGGTTATGCTGGGGGCTCAGATCACCGTAGACAACTGGACACTCAGGACCACGCCATGGAGGAGCTGCAGGATGATTATGAAGACATGATGGAGGAGAATCTGGAGCAGGAGGAATATGAAGACCCAGACATCCCCGAGTCCCAGATGGAGGAGCCGGCAGCTCACGACACCGAGGCAACAGCCACAGACTACCACACCACATCACACCCGGGTACCCACGAGGTCTATGTGGAGCTGCAGGAGCTGGTGATGGACGAAAAGAACCAGGAGCTGAGATGGATGGAGGCGGCGCGCTGGGTGCAACTGGAGGAGAACCTGGGGGAGAATGGGGCCTGGGGCCGCCCGCACCTCTCTCACCTCACCTTCTGGAGCCTCCTAGAGCTGCGTAGAGTCTTCACCAAGGGTACTGTCCTCCTAGACCTGCAAGAGACCTCCCTGGCTGGAGTGGCCAACCAACTGCTAGACAGGTTTATCTTTGAAGACCAGATCCGGCCTCAGGACCGAGAGGAGCTGCTCCGGGCCCTGCTGCTTAAACACAGCCACGCTGGAGAGCTGGAGGCCCTGGGGGGTGTGAAGCCTGCAGTCCTGACACGCTCTGGGGATCCTTCACAGCCTCTGCTCCCCCAACACTCCTCACTGGAGACACAGCTCTTCTGTGAGCAGGGAGATGGGGGCACAGAAGGGCACTCACCATCTGGAATTCTGGAAAAGATTCCCCCGGATTCAGAGGCCACGTTGGTGCTAGTGGGCCGCGCCGACTTCCTGGAGCAGCCGGTGCTGGGCTTCGTGAGGCTGCAGGAGGCAGCGGAGCTGGAGGCGGTGGAGCTGCCGGTGCCTATACGCTTCCTCTTTGTGTTGCTGGGACCTGAGGCCCCCCACATCGATTACACCCAGCTTGGCCGGGCTGCTGCCACCCTCATGTCAGAGAGGGTGTTCCGCATAGATGCCTACATGGCTCAGAGCCGAGGGGAGCTGCTGCACTCCCTAGAGGGCTTCCTGGACTGCAGCCTAGTGCTGCCTCCCACCGATGCCCCCTCCGAGCAGGCACTGCTCAGTCTGGTGCCTGTGCAGAGGGAGCTACTTCGAAGGCGCTATCAGTCCAGCCCTGCCAAGCCAGACTCCAGCTTCTACAAGGGCCTAGACTTAAATGGGGGCCCAGATGACCCTCTGCAGCAGACAGGCCAGCTCTTCGGGGGCCTGGTGCGTGATATCCGGCGCCGCTACCCCTATTACCTGAGTGACATCACAGATGCATTCAGCCCCCAGGTCCTGGCTGCCGTCATCTTCATCTACTTTGCTGCACTGTCACCCGCCATCACCTTCGGCGGCCTCCTGGGAGAAAAGACCCGGAACCAGATGGGAGTGTCGGAGCTGCTGATCTCCACTGCAGTGCAGGGCATTCTCTTCGCCCTGCTGGGGGCTCAGCCCCTGCTTGTGGTCGGCTTCTCAGGACCCCTGCTGGTGTTTGAGGAAGCCTTCTTCTCGTTCTGCGAGACCAACGGTCTAGAGTACATCGTGGGCCGCGTGTGGATCGGCTTCTGGCTCATCCTGCTGGTGGTGTTGGTGGTGGCCTTCGAGGGTAGCTTCCTGGTCCGCTTCATCTCCCGCTATACCCAGGAGATCTTCTCCTTCCTCATTTCCCTCATCTTCATCTATGAGACTTTCTCCAAGCTGATCAAGATCTTCCAGGACCACCCACTACAGAAGACTTATAACTACAACGTGTTGATGGTGCCCAAACCTCAGGGCCCCCTGCCCAACACAGCCCTCCTCTCCCTTGTGCTCATGGCCGGTACCTTCTTCTTTGCCATGATGCTGCGCAAGTTCAAGAACAGCTCCTATTTCCCTGGCAAGCTGCGTCGGGTCATCGGGGACTTCGGGGTCCCCATCTCCATCCTGATCATGGTCCTGGTGGATTTCTTCATTCAGGATACCTACACCCAGAAACTCTCGGTGCCTGATGGCTTCAAGGTGTCCAACTCCTCAGCCCGGGGCTGGGTCATCCACCCACTGGGCTTGCGTTCCGAGTTTCCCATCTGGATGATGTTTGCCTCCGCCCTGCCTGCTCTGCTGGTCTTCATCCTCATATTCCTGGAGTCTCAGATCACCACGCTGATTGTCAGCAAACCTGAGCGCAAGATGGTCAAGGGCTCCGGCTTCCACCTGGACCTGCTGCTGGTAGTAGGCATGGGTGGGGTGGCCGCCCTCTTTGGGATGCCCTGGCTCAGTGCCACCACCGTGCGTTCCGTCACCCATGCCAACGCCCTCACTGTCATGGGCAAAGCCAGCACCCCAGGGGCTGCAGCCCAGATCCAGGAGGTCAAAGAGCAGCGGATCAGTGGACTCCTGGTCGCTGTGCTTGTGGGCCTGTCCATCCTCATGGAGCCCATCCTGTCCCGCATCCCCCTGGCTGTACTGTTTGGCATCTTCCTCTACATGGGGGTCACGTCGCTCAGCGGCATCCAGCTCTTTGACCGCATCTTGCTTCTGTTCAAGCCACCCAAGTATCACCCAGATGTGCCCTACGTCAAGCGGGTGAAGACCTGGCGCATGCACTTATTCACGGGCATCCAGATCATCTGCCTGGCAGTGCTGTGGGTGGTGAAGTCCACGCCGGCCTCCCTGGCCCTGCCCTTCGTCCTCATCCTCACTGTGCCGCTGCGGCGCGTCCTGCTGCCGCTCATCTTCAGGAACGTGGAGCTTCAGTGTCTGGATGCTGATGATGCCAAGGCAACCTTTGATGAGGAGGAAGGTCGGGATGAATACGACGAAGTGGCCATGCCTGTGTGAGGGGCGGGCCCAGGCCCTAGACCCTCCCCCACCATTCCACATCCCCACCTTCCAAGGAAAAGCAGAAGTTCATGGGCACCTCATGGACTCCAGGATCCTCCTGGAGCAGCAGCTGAGGCCCCAGGGCTGTGGGTGGGGAAGGAAGGCGTGTCCAGGAGACCTTCCACAAAGGGTAGCCTGGCTTTTCTGGCTGGGGATGGCCGATGGGGCCCACATTAGGGGGTTTGTTGCACAGTCCCTCCTGTTGCCACACTTTCACTGGGGATCCCGTGCTGGAAGACTTAGATCTGAGCCCTCCCTCTTCCCAGCACAGGCAGGGGTAGAAGCAAAGGCAGGAGGTGGGTGAGCGGGTGGGGTGCTTGCTGTGTGACCTTGGGCAAGTCCCTTGACCTTTCCAGCCTATATTTCCTCTTCTGTAAAATGGGTATATTGATGATAATACCCACATTACAGGATGGTTACTGAGGACCAAAGATACATGTAAAATAGGGCTTTGTAAACTCCACAGGGACTGTTCTATAGCAGTCATCATTTGTCTTTGAACGTACCCAAGGTCACATAGCTGGGATTTGAACTGAGCCGTGCAGCT</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Erythrocytes</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane Associated</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>SLC4A1</Gene_Name>
    <Gene_Alias>AE1; DI; EPB3</Gene_Alias>
    <Gene_ID>6521</Gene_ID>
    <Genbank_ACCN>NM_000342</Genbank_ACCN>
    <Protein_ACCN>NP_000333</Protein_ACCN>
    <HGNC_ID>11027</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/6521</Gene_URL>
    <UCSC_ID>uc002igf.4</UCSC_ID>
    <EMBL_ID>ENSG00000114923</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Acanthocytosis</Disease_Name>
      <Disease_Detail>Acanthocytosis</Disease_Detail>
      <Disease_DB>ACN014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acanthocytosis?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Spherocytosis, Type 4</Disease_Name>
      <Disease_Detail>Spherocytosis, Type 4</Disease_Detail>
      <Disease_DB>SPH016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spherocytosis_type_4?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Renal Tubular Acidosis, Distal, Autosomal Dominant</Disease_Name>
      <Disease_Detail>Renal Tubular Acidosis</Disease_Detail>
      <Disease_DB>RNL046</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/renal_tubular_acidosis_distal_autosomal_dominant?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Respiratory Failure</Disease_Name>
      <Disease_Detail>Respiratory Failure</Disease_Detail>
      <Disease_DB>RSP003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/respiratory_failure?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Renal Tubular Acidosis, Distal, Ar</Disease_Name>
      <Disease_Detail>Renal Tubular Acidosis</Disease_Detail>
      <Disease_DB>RNL067</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/renal_tubular_acidosis_distal_ar?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Slc4a1-Related Spherocytosis</Disease_Name>
      <Disease_Detail>Slc4a1-Related Spherocytosis</Disease_Detail>
      <Disease_DB>SLC023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/slc4a1_related_spherocytosis?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Renal Tubular Acidosis, Distal, Autosomal Recessive</Disease_Name>
      <Disease_Detail>Renal Tubular Acidosis</Disease_Detail>
      <Disease_DB>RNL047</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/renal_tubular_acidosis_distal_autosomal_recessive?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Renal Tubular Acidosis</Disease_Name>
      <Disease_Detail>Renal Tubular Acidosis</Disease_Detail>
      <Disease_DB>RNL007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/renal_tubular_acidosis?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Renal Tubular Acidosis, Distal, Ad</Disease_Name>
      <Disease_Detail>Renal Tubular Acidosis</Disease_Detail>
      <Disease_DB>RNL066</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/renal_tubular_acidosis_distal_ad?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Blood Group Incompatibility</Disease_Name>
      <Disease_Detail>Blood Group Incompatibility</Disease_Detail>
      <Disease_DB>BLD052</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/blood_group_incompatibility?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Kernicterus</Disease_Name>
      <Disease_Detail>Kernicterus</Disease_Detail>
      <Disease_DB>KRN004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/kernicterus?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pendred Syndrome</Disease_Name>
      <Disease_Detail>Pendred Syndrome</Disease_Detail>
      <Disease_DB>PND002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pendred_syndrome?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Malaria</Disease_Name>
      <Disease_Detail>Malaria</Disease_Detail>
      <Disease_DB>MLR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/malaria?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Plasmodium Falciparum Malaria</Disease_Name>
      <Disease_Detail>Plasmodium Falciparum Malaria</Disease_Detail>
      <Disease_DB>PLS007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/plasmodium_falciparum_malaria?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovalocytosis, Southeast Asian</Disease_Name>
      <Disease_Detail>Ovalocytosis, Southeast Asian</Disease_Detail>
      <Disease_DB>OVL001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovalocytosis_southeast_asian?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chorea-Acanthocytosis</Disease_Name>
      <Disease_Detail>Chorea-Acanthocytosis</Disease_Detail>
      <Disease_DB>CHR452</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chorea_acanthocytosis?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hereditary Cryohydrocytosis with Normal Stomatin</Disease_Name>
      <Disease_Detail>Hereditary Cryohydrocytosis with Normal Stomatin</Disease_Detail>
      <Disease_DB>HRD134</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hereditary_cryohydrocytosis_with_normal_stomatin?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cor Pulmonale</Disease_Name>
      <Disease_Detail>Cor Pulmonale</Disease_Detail>
      <Disease_DB>CRP018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cor_pulmonale?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nephrocalcinosis</Disease_Name>
      <Disease_Detail>Nephrocalcinosis</Disease_Detail>
      <Disease_DB>NPH003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nephrocalcinosis?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Renal Tubular Acidosis, Distal</Disease_Name>
      <Disease_Detail>Renal Tubular Acidosis</Disease_Detail>
      <Disease_DB>RNL045</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/renal_tubular_acidosis_distal?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Renal Tubular Acidosis, Distal, with Hemolytic Anemia</Disease_Name>
      <Disease_Detail>Renal Tubular Acidosis</Disease_Detail>
      <Disease_DB>RNL054</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/renal_tubular_acidosis_distal_with_hemolytic_anemia?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hereditary Spherocytosis</Disease_Name>
      <Disease_Detail>Hereditary Spherocytosis</Disease_Detail>
      <Disease_DB>HRD011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hereditary_spherocytosis?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hereditary Elliptocytosis</Disease_Name>
      <Disease_Detail>Hereditary Elliptocytosis</Disease_Detail>
      <Disease_DB>HRD012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hereditary_elliptocytosis?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Priapism</Disease_Name>
      <Disease_Detail>Priapism</Disease_Detail>
      <Disease_DB>PRP007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/priapism?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Rift Valley Fever</Disease_Name>
      <Disease_Detail>Rift Valley Fever</Disease_Detail>
      <Disease_DB>RFT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/rift_valley_fever?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemolytic Anemia Due to Band 3 Montefiore</Disease_Name>
      <Disease_Detail>Hemolytic Anemia</Disease_Detail>
      <Disease_DB>HML019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemolytic_anemia_due_to_band_3_montefiore?search=SLC4A1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>THE SOLUTION STRUCTURES OF THE FIRST AND SECOND TRANSMEMBRANE-SPANNING SEGMENTS OF BAND 3</PDB_Title>
      <PDB_ID>1BTQ</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BTQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The solution structures of the first and second transmembrane-spanning segments of band 3.</PubMed_Title>
      <Author>Gargaro AR, et al.</Author>
      <Journal>Eur J Biochem. 1994 Apr 1;221(1):445-54.</Journal>
      <PubMed_ID>8168533</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR STUDY OF N-TERMINAL HUMAN BAND 3 PEPTIDE, RESIDUES 1-15</PDB_Title>
      <PDB_ID>2BTB</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2BTB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of a band 3 peptide inhibitor bound to aldolase: a proposed mechanism for regulating binding by tyrosine phosphorylation.</PubMed_Title>
      <Author>Schneider ML, et al.</Author>
      <Journal>Biochemistry. 1995 Dec 26;34(51):16574-84.</Journal>
      <PubMed_ID>8527430</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A LOW ENERGY STRUCTURE FOR THE FINAL CYTOPLASMIC LOOP OF BAND 3, NMR, MINIMIZED AVERAGE STRUCTURE</PDB_Title>
      <PDB_ID>1BH7</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BH7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>NMR solution structure of a cytoplasmic surface loop of the human red cell anion transporter, band 3.</PubMed_Title>
      <Author>Askin D, et al.</Author>
      <Journal>Biochemistry. 1998 Aug 18;37(33):11670-8.</Journal>
      <PubMed_ID>9709005</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE SOLUTION STRUCTURES OF THE FIRST AND SECOND TRANSMEMBRANE-SPANNING SEGMENTS OF BAND 3</PDB_Title>
      <PDB_ID>1BTS</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BTS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The solution structures of the first and second transmembrane-spanning segments of band 3.</PubMed_Title>
      <Author>Gargaro AR, et al.</Author>
      <Journal>Eur J Biochem. 1994 Apr 1;221(1):445-54.</Journal>
      <PubMed_ID>8168533</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURAL STUDIES ON THE EFFECTS OF THE DELETION IN THE RED CELL ANION EXCHANGER (BAND3, AE1) ASSOCIATED WITH SOUTH EAST ASIAN OVALOCYTOSIS.</PDB_Title>
      <PDB_ID>1BNX</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BNX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Studies on the structure of a transmembrane region and a cytoplasmic loop of the human red cell anion exchanger (band 3, AE1).</PubMed_Title>
      <Author>Chambers EJ, et al.</Author>
      <Journal>Biochem Soc Trans. 1998 Aug;26(3):516-20.</Journal>
      <PubMed_ID>9765907</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF HUMAN ERYTHROCYTE BAND-3 PROTEIN</PDB_Title>
      <PDB_ID>1HYN</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HYN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3.</PubMed_Title>
      <Author>Zhang D, et al.</Author>
      <Journal>Blood. 2000 Nov 1;96(9):2925-33.</Journal>
      <PubMed_ID>11049968</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURAL STUDIES ON THE EFFECTS OF THE DELETION IN THE RED CELL ANION EXCHANGER (BAND3, AE1) ASSOCIATED WITH SOUTH EAST ASIAN OVALOCYTOSIS.</PDB_Title>
      <PDB_ID>1BZK</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BZK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural studies on the effects of the deletion in the red cell anion exchanger (band 3, AE1) associated with South East Asian ovalocytosis.</PubMed_Title>
      <Author>Chambers EJ, et al.</Author>
      <Journal>J Mol Biol. 1999 Jan 22;285(3):1289-307.</Journal>
      <PubMed_ID>9887277</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE SOLUTION STRUCTURES OF THE FIRST AND SECOND TRANSMEMBRANE-SPANNING SEGMENTS OF BAND 3</PDB_Title>
      <PDB_ID>1BTT</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BTT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The solution structures of the first and second transmembrane-spanning segments of band 3.</PubMed_Title>
      <Author>Gargaro AR, et al.</Author>
      <Journal>Eur J Biochem. 1994 Apr 1;221(1):445-54.</Journal>
      <PubMed_ID>8168533</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR SOLUTION STRUCTURE OF A BAND 3 PEPTIDE INHIBITOR BOUND TO GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE, 20 STRUCTURES</PDB_Title>
      <PDB_ID>3BTB</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3BTB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Insights into tyrosine phosphorylation control of protein-protein association from the NMR structure of a band 3 peptide inhibitor bound to glyceraldehyde-3-phosphate dehydrogenase.</PubMed_Title>
      <Author>Eisenmesser EZ, et al.</Author>
      <Journal>Biochemistry. 1998 Jan 20;37(3):867-77.</Journal>
      <PubMed_ID>9454576</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE SOLUTION STRUCTURES OF THE FIRST AND SECOND TRANSMEMBRANE-SPANNING SEGMENTS OF BAND 3</PDB_Title>
      <PDB_ID>1BTR</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BTR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The solution structures of the first and second transmembrane-spanning segments of band 3.</PubMed_Title>
      <Author>Gargaro AR, et al.</Author>
      <Journal>Eur J Biochem. 1994 Apr 1;221(1):445-54.</Journal>
      <PubMed_ID>8168533</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR STUDY OF N-TERMINAL HUMAN BAND 3 PEPTIDE, RESIDUES 1-15</PDB_Title>
      <PDB_ID>2BTA</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2BTA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of a band 3 peptide inhibitor bound to aldolase: a proposed mechanism for regulating binding by tyrosine phosphorylation.</PubMed_Title>
      <Author>Schneider ML, et al.</Author>
      <Journal>Biochemistry. 1995 Dec 26;34(51):16574-84.</Journal>
      <PubMed_ID>8527430</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.cec.b.c.b.html</SCOP_URL>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1hyn</CATH_URL>
  </Fold>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00390001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00390002</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00390003</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00390004</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00390005</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00390006</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>